Autoantibody profile in patients with PAPS, patients with unexplained pregnancy morbidity, and patients with SLE
| aPL positive No (%) | aCL No (%) | IgG aCL No (%) | IgM aCL No (%) | LA No (%) | aβ2GPI No (%) | IgG aβ2GPI No (%) | IgM aβ2GPI No (%) | |
|---|---|---|---|---|---|---|---|---|
| PAPS, primary antiphospholipid syndrome; SLE, systemic lupus erythematosus; aPL, antiphospholipid antibodies; aCL, anticardiolipin antibodies; LA, lupus anticoagulant. | ||||||||
| None from the group with unexplained pregnancy morbidity and 19 patients from the group with SLE fulfilled the Sapporo criteria for the APS. | ||||||||
| PAPS (n=28) | 28 (100) | 26 (93) | 14 (50) | 25 (89) | 15 (54) | 13 (46) | 12 (43) | 4 (14) |
| Unexplained pregnancy morbidity (n=28) | 9 (32) | 9 (32) | 2 (7) | 8 (29) | 0 (0) | 8 (29) | 7 (25) | 1 (4) |
| SLE (n=28) | 21 (75) | 21 (75) | 20 (71) | 20 (71) | 5 (18) | 11 (39) | 10 (36) | 4 (14) |